These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Acute adenosine increases cardiac vagal and reduces sympathetic efferent nerve activities in rats. da Silva VJ; Gnecchi-Ruscone T; Bellina V; Oliveira M; Maciel L; de Carvalho AC; Salgado HC; Bergamaschi CM; Tobaldini E; Porta A; Montano N Exp Physiol; 2012 Jun; 97(6):719-29. PubMed ID: 22366563 [TBL] [Abstract][Full Text] [Related]
67. Effects of chronic clonidine administration on sympathetic nerve traffic and baroreflex function in heart failure. Grassi G; Turri C; Seravalle G; Bertinieri G; Pierini A; Mancia G Hypertension; 2001 Aug; 38(2):286-91. PubMed ID: 11509491 [TBL] [Abstract][Full Text] [Related]
68. Effect of aspirin and ifetroban on skeletal muscle blood flow in patients with congestive heart failure treated with Enalapril. Ifetroban Study Group. Katz SD; Radin M; Graves T; Hauck C; Block A; LeJemtel TH J Am Coll Cardiol; 1999 Jul; 34(1):170-6. PubMed ID: 10400007 [TBL] [Abstract][Full Text] [Related]
69. Angiotensin converting enzyme inhibitors in congestive heart failure. Overview in comparison of captopril and enalapril. Levine TB; Olivari MT; Cohn JN Am J Med; 1986 Oct; 81(4C):36-9. PubMed ID: 3022583 [TBL] [Abstract][Full Text] [Related]
70. Effect of enalapril maleate on cerebral blood flow in patients with chronic heart failure. Kamishirado H; Inoue T; Fujito T; Kase M; Shimizu M; Sakai Y; Takayanagi K; Morooka S; Natsui S Angiology; 1997 Aug; 48(8):707-13. PubMed ID: 9269140 [TBL] [Abstract][Full Text] [Related]
71. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians. Adewole AD; Ikem RT; Adigun AQ; Akintomide AO; Balogun MO; Ajayi AA Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572 [TBL] [Abstract][Full Text] [Related]
72. Comparison of early and late start of antihypertensive agents and baroreceptor reflexes. Kumagai K; Suzuki H; Ichikawa M; Jimbo M; Nishizawa M; Ryuzaki M; Saruta T Hypertension; 1996 Feb; 27(2):209-18. PubMed ID: 8567043 [TBL] [Abstract][Full Text] [Related]
73. Effects of high-carbohydrate and high-fat dietary treatments on measures of heart rate variability and sympathovagal balance. Millis RM; Austin RE; Bond V; Faruque M; Goring KL; Hickey BM; Blakely R; Demeersman RE Life Sci; 2009 Jul; 85(3-4):141-5. PubMed ID: 19465030 [TBL] [Abstract][Full Text] [Related]
74. The autonomic nervous system in congestive heart failure. Francis GS; Cohn JN Annu Rev Med; 1986; 37():235-47. PubMed ID: 2871803 [TBL] [Abstract][Full Text] [Related]
75. Enalapril: a new angiotensin-converting enzyme inhibitor. McRaith J; Fitz A Iowa Med; 1986 Oct; 76(10):482, 484, 486-8. PubMed ID: 3023256 [No Abstract] [Full Text] [Related]
78. Physiology and pathophysiology of baroreceptor function and neuro-hormonal abnormalities in heart failure. Kirchheim HR; Just A; Ehmke H Basic Res Cardiol; 1998; 93 Suppl 1():1-22. PubMed ID: 9833126 [No Abstract] [Full Text] [Related]
79. Vagal mediation of the effect of alcohol on heart rate. Newlin DB; Byrne EA; Porges SW Alcohol Clin Exp Res; 1990 Jun; 14(3):421-4. PubMed ID: 2378426 [TBL] [Abstract][Full Text] [Related]
80. Antioxidant therapy in congestive heart failure: is there any advantage? Ganguly PK J Intern Med; 1991 Mar; 229(3):205-8. PubMed ID: 2007838 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]